Prognostic value of plasminogen activator inhibitor-1 in head and neck squamous cell carcinoma.
about
uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy.Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer.Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients.Hypoxia induces TFE3 expression in head and neck squamous cell carcinomaPlasminogen activator inhibitor-1 enhances radioresistance and aggressiveness of non-small cell lung cancer cellsCharacteristics of the level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1.Clinical utility of level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1.Targeting tumor hypoxia in nasopharyngeal carcinoma.Impact of proteolytic enzymes in colorectal cancer development and progression.ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer.Plasminogen activator inhibitor-1 as regulator of tumor-initiating cell properties in head and neck cancers.Upregulation of Plasminogen Activator Inhibitor-1 in Irradiated Recipient Arteries and Veins from Free Tissue Transfer Reconstruction in Cancer Patients
P2860
Q30249137-57816158-ABD2-4C10-BB1E-186E93F314BCQ33350682-D155E9A1-FA63-4CE6-A243-0B30D73859F6Q36557197-A97A3AB4-6816-4824-ACE8-A33A623879D2Q36998335-44F8D6F5-828C-442E-8232-D3E39A182472Q37269183-F846FC64-D924-4824-823D-08652ECFB36AQ37801943-3B8513B8-10EF-4D13-A57B-BEBA11CD0CC5Q37809871-191A3CDF-14B1-4DA1-80CA-EB18ACBECE74Q37959387-4C0B3A0F-DDDD-4C58-B057-62569249D036Q38259533-E8B4760F-B3F6-4AAD-8390-1D7BC5F0CE1CQ39422383-93D65471-90A6-4409-B7AC-95CED07D0157Q53505997-079FBB07-D75E-4EE3-922D-2194C1018121Q58584606-69547CAA-760F-4F65-89EE-98C54D3824BB
P2860
Prognostic value of plasminogen activator inhibitor-1 in head and neck squamous cell carcinoma.
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Prognostic value of plasminoge ...... neck squamous cell carcinoma.
@ast
Prognostic value of plasminoge ...... neck squamous cell carcinoma.
@en
Prognostic value of plasminoge ...... neck squamous cell carcinoma.
@nl
type
label
Prognostic value of plasminoge ...... neck squamous cell carcinoma.
@ast
Prognostic value of plasminoge ...... neck squamous cell carcinoma.
@en
Prognostic value of plasminoge ...... neck squamous cell carcinoma.
@nl
prefLabel
Prognostic value of plasminoge ...... neck squamous cell carcinoma.
@ast
Prognostic value of plasminoge ...... neck squamous cell carcinoma.
@en
Prognostic value of plasminoge ...... neck squamous cell carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Prognostic value of plasminoge ...... neck squamous cell carcinoma.
@en
P2093
Cees A Meeuwis
Els M J J Berns
Jeroen D F Kerrebijn
John A Foekens
Luciënne Speleman
Maxime P Look
P2860
P304
P356
10.1002/HED.20527
P577
2007-04-01T00:00:00Z